Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

3.14
+0.850037.12%
Post-market: 3.240.1000+3.18%19:59 EDT
Volume:12.64M
Turnover:41.67M
Market Cap:218.70M
PE:-0.60
High:3.78
Open:2.33
Low:2.33
Close:2.29
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Major Issues Report

8-K - Current report
Feb 02, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Jan 03, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Major Issues Report

8-K - Current report
Oct 24, 2022

Major Issues Report

8-K - Current report
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 23, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]